# A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)

> **NCT03785366** · PHASE3 · COMPLETED · sponsor: **Sebela Women's Health Inc.** · enrollment: 41 (actual)

## Conditions studied

- Women at Risk for Pregnancy

## Interventions

- **DRUG:** VeraCept
- **DRUG:** ParaGard

## Key facts

- **NCT ID:** NCT03785366
- **Lead sponsor:** Sebela Women's Health Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-17
- **Primary completion:** 2019-12-30
- **Final completion:** 2024-08-01
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2025-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03785366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03785366, "A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03785366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*